About This Site

gangnam-ultherapy-prime.com is an English-language editorial archive about Ultherapy and Ultherapy Prime in Korea — the device, the protocol, the cost, the recovery, and the city you recover in. It is written for U.S. and international readers who are seriously considering traveling to Seoul for treatment, and it is read by the kind of person who actually wants to know what the literature says, what the recovery feels like, and what the operator structure behind the site is. Below: the mission, the audience, what's covered, what isn't, and the publisher.

Mission

The mission of this site is narrow on purpose — to be the English-speaking guide to Ultherapy and Ultherapy Prime in Korea, written carefully, hedged appropriately, and disclosed transparently. I am writing the archive I wish had existed when I was researching my own first treatment in 2022: long-form, first-person where it makes sense, plainspoken, citing the actual published literature and the actual regulatory framework rather than parroting clinic marketing. The narrow scope is deliberate. There are dozens of sites that try to cover all of K-beauty in English; almost none of them go deep on a single device family, and the ones that do tend to be either a single clinic's blog or a content farm. I am trying to be neither.

Audience — U.S. readers traveling for treatment

The primary reader I write for is a U.S.-based 30-to-55-year-old who is researching Ultherapy or Ultherapy Prime, has compared the U.S. and Korean cost differential, and is at least curious about flying to Seoul for the treatment. Secondary readers include international English speakers — Singapore, Australia, the UK, Canada — researching the same thing, and Korean-American readers who are revisiting the home country for treatments their parents and aunts have been quietly getting for years. The writing assumes some prior knowledge — you've at least Googled what Ultherapy is — and assumes you would like more than a bullet-pointed listicle in return for your reading time. If you want a five-paragraph overview, the glossary is the right entry point. If you want the long-form coverage, the treatment guides and listicles are.

What's covered — six categories

The archive is organized into six categories — treatment guides, travel, listicles, glossary, news, and hospital hubs — each treated as long-form rather than reference, and each revised when the underlying facts shift.

• Treatment guides — what Ultherapy and Ultherapy Prime do, how the device works, indications, the session itself, recovery, side effects, comparisons against Sofwave / Thermage / RF microneedling, and adjacent decisions (combining with botox, fillers, thread lift)
• Travel — Gangnam city pieces, recovery-friendly itineraries, hotels, restaurants, walks, and the practical logistics of an LA-to-ICN treatment trip
• Listicles — Featured / Editorial-pick categorical roundups of clinics, cafes, recovery foods, photo spots, and adjacent decisions; never ranked, in keeping with 의료법 제56조 4항
• Glossary — A-to-Z definitions of the terms a careful reader will encounter (MFU, dermis, SMAS, lines, dual-depth, focal coagulation zone), structured for AEO and direct-pull surfaces
• News — regulatory updates (FDA, KFDA), clinical-data releases, pricing changes in Korea, and device recalls or notices, dated and updated by appendix rather than silently rewritten
• Hospital hubs — categorical hospital introductions with the WhatsApp coordinator channel; the only category that carries a CTA

What's not covered

The archive does not cover surgery — facelifts, blepharoplasty, rhinoplasty, jaw contouring — or other invasive procedures; readers researching surgical interventions are better served by a surgical-specialty publication. It does not cover non-aesthetic medicine — orthopedics, dental, fertility — even where those categories overlap with medical-tourism logistics. It does not cover K-pop, idol culture, fashion, or general lifestyle K-content. It does not cover clinics outside the Seoul aesthetic-medicine corridor, and within that corridor it covers clinics categorically rather than as a ranked recommendation list. The narrow scope is what makes the archive useful; trying to cover everything would dilute the coverage and break the editorial firewall the publisher disclosure rests on.

Publisher — HEIM GLOBAL

This site is published by HEIM GLOBAL, a Korean medical-tourism marketing agency registered with the Ministry of Health and Welfare under foreign-patient registration A-2026-04-02-06873 and with the Korean tax authority under business-registration number 405-04-54000. The representative director is Oh Su-ji (오수지). HEIM GLOBAL operates a small publisher network of English- and other-language editorial sites covering Korean aesthetic medicine, of which gangnam-ultherapy-prime.com is one; sister domains in the network cover stem cell therapy, Thermage FLX, Sofwave, and adjacent device categories from different editorial perspectives. The Hospital Hub pages on this site carry a HEIM GLOBAL WhatsApp coordinator channel that introduces readers to affiliated clinics and may earn the publisher a referral fee on bookings — that is the entire commercial structure of the site. The general editorial coverage is paid for under a flat editorial budget and is not sponsored at the article level. Operator details are reproduced in the footer of every page on the site for the regulatory baseline that 의료법 제56조 제4항 and the foreign-patient framework require.

“Operated by HEIM GLOBAL · 사업자등록번호 405-04-54000 · 외국인환자 유치 등록번호 A-2026-04-02-06873 · 대표 오수지 · contact: [email protected]”

Operator block, reproduced in the footer of every page on the site

Frequently asked questions

Is this a clinic site?

No. It is an editorial archive published by HEIM GLOBAL, a Korean medical-tourism marketing agency. The site does not provide treatments, employ clinicians, or operate a clinic. The Hospital Hub pages introduce readers to a HEIM GLOBAL WhatsApp coordinator channel, which routes inquiries to affiliated clinical operators in Gangnam and elsewhere in Seoul. Reading the site does not create a doctor-patient relationship — see the medical disclaimer.

Why so much focus on a single device family?

Because going deep on a narrow scope produces better coverage than going wide on a broad one. Ultherapy and Ultherapy Prime are the platform a meaningful share of U.S. readers come to Korea specifically for, and the English-language coverage of the device — especially the Korean version of the protocol and the cost differential — is undersupplied. The narrow scope is a deliberate editorial choice, not a content-farm constraint.